AI
The New York-based company will use the funds to grow its team, continue expanding into health systems and accelerate product innovation.
Developers see a potential use of the AI-powered mobile solution for routine early skin cancer screening.
Interestingly, young physicians see more risk to it than their senior counterparts.
It has shown 82% accuracy in detecting stroke, comparable to paramedics, according to RMIT University.
Also, digital twin technology is being tested to optimise mechanical ventilation.
The company offers a clinical vetting process and care-management pathway for individuals suffering from substance use disorders.
Also, a gastric cancer detection tool in India has received a breakthrough designation from the US FDA.
Also, Consultmed has released a new genAI feature on its referral management software.
The organizations will codevelop algorithms to help healthcare professionals analyze point-of-care ultrasound images for cardiac care.
Cardiac and lung-disease platform Eko Health secured $41 million in Series D funding.